Showing results (1131-1140 of 1,148) with videos related to
Sort By:
Pageof 115
Nature Medicine|March 1, 2022
Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1John A McCulloch, Diwakar Davar, Richard R Rodrigues, et al.Cellular Immunology|November 13, 2017
Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasisDaniel S Dias, Patrícia A F Ribeiro, Vívian T Martins, et al.Journal of Neurology|February 22, 2012
Incidence of acquired demyelinating syndromes of the CNS in Dutch children: a nationwide studyI A Ketelslegers, C E Catsman-Berrevoets, R F Neuteboom, et al.Neurology|September 2, 2025
Frequency and Diagnostic Implications of Paramagnetic Rim Lesions in People Presenting for Diagnosis to a Multiple Sclerosis ClinicBrian Renner, Elizabeth Daphne Verter, Martina Absinta, et al.Science Advances|August 5, 2017
Genome-wide signatures of complex introgression and adaptive evolution in the big catsHenrique V Figueiró, Gang Li, Fernanda J Trindade, et al.Science (New York, N.Y.)|February 5, 2021
Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patientsDiwakar Davar, Amiran K Dzutsev, John A McCulloch, et al.Diagnostics (Basel, Switzerland)|August 7, 2021
Host-Pathogen Adhesion as the Basis of Innovative Diagnostics for Emerging PathogensAlex van Belkum, Carina Almeida, Benjamin Bardiaux, et al.Neurology|June 12, 2026
Application of the 2024 McDonald Criteria in Individuals With Nonspecific Symptoms or Incidental Imaging Findings in a Multicenter StudyAlexandra Scharf, Jeffrey A Cohen, Ruth Ann Marrie, et al.Hypertension (Dallas, Tex. : 1979)|February 22, 2018
Spironolactone Versus Clonidine as a Fourth-Drug Therapy for Resistant Hypertension: The ReHOT Randomized Study (Resistant Hypertension Optimal Treatment)Eduardo M Krieger, Luciano F Drager, Dante M A Giorgi, et al.Science (New York, N.Y.)|April 25, 2024
Vitamin D regulates microbiome-dependent cancer immunityEvangelos Giampazolias, Mariana Pereira da Costa, Khiem C Lam, et al.Pageof 115